Citations

Showing 10 of 108152 citations.

Neuroscience for Clinicians
Benarroch, Eduardo E.

Mayo Clinic

No container title available | May 5, 2021 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1093/med/9780190948894.001.0001 Get It

Abstract The aim of this book is to provide the clinician with a comprehensive and clinical relevant survey of emerging concepts on the organization and function of the nervous system and neurologic disease mechanisms, at the molecular, cellular, and system levels. The content of is based on the review of information obtained from recent advances in genetic, molecular, and cell biology techniques; electrophysiological recordings; brain mapping; and mouse models, emphasizing the clinical and possible therapeutic implications. Many chapters of this book contain information that will be relevant not only to clinical neurologists but also to psychiatrists and physical therapists. The scope includes the mechanisms and abnormalities of DNA/RNA metabolism, proteostasis, vesicular biogenesis, and axonal transport and mechanisms of neurodegeneration; the role of the mitochondria in cell function and death mechanisms; ion channels, neurotransmission and mechanisms of channelopathies and synaptopathies; the functions of astrocytes, oligodendrocytes, and microglia and their involvement in disease; the local circuits and synaptic interactions at the level of the cerebral cortex, thalamus, basal ganglia, cerebellum, brainstem, and spinal cord transmission regulating sensory processing, behavioral state, and motor functions; the peripheral and central mechanisms of pain and homeostasis; and networks involved in emotion, memory, language, and executive function.
Characterizing the need for multiple epidural blood patches in the treatment of postdural puncture headache: an observational study
Barman, Ross , Kurian, Emil B., Eldrige, Jason S. , Frank, Ryan D. , Garza, Ivan , Whealy, Mark , Cutsforth‐Gregory, Jeremy K. , Olatoye, Oludare, Mustafa, Rafid , Barman, Ross A , Eldrige, Jason, Frank, Ryan, Whealy, Mark A , Olatoye, Oludare , Kissoon, Narayan

Mayo Clinic

Regional Anesthesia & Pain Medicine | May 5, 2021 | Volume: 46 | Issue: 12 | Pages: 1110-1112

10.1136/rapm-2021-102692 | PMID 33952685 Get It

Consistent safety and tolerability of Valtoco® (diazepam nasal spray) in relationship to usage frequency in patients with seizure clusters: Interim results from a phase 3, long‐term, open‐label, repeat‐dose safety study
Miller, Ian , Dlugos, Dennis , Biton, Victor, Cascino, Gregory D. , Sperling, Michael R. , Liow, Kore , Vázquez, Blanca , Segal, Eric , Mauney, Weldon, Desai, Jay , Group, The DIAZ.001.05 Study, Hogan, R Edward , Sperling, Michael R , Miller, Ian , Wheless, James W. , Tarquinio, Daniel Charles , Rabinowicz, Adrián L. , Carrazana, Enrique , Group, The DIAZ.001.05 Study

Mayo Clinic

Epilepsia Open | May 5, 2021 | Volume: 6 | Issue: 3 | Pages: 504-512

10.1002/epi4.12494 | PMID 34033266 Get It

AbstractObjectiveNeed for rescue therapy differs among patients with seizure clusters. Diazepam nasal spray is approved to treat seizure clusters in patients with epilepsy ≥6 years of age. This analysis used interim data from a phase 3 safety study to assess safety profile and effectiveness of diazepam nasal spray using average number of doses/month as a proxy measurement.MethodsThis phase 3, open‐label, repeat‐dose, safety study of diazepam nasal spray enrolled patients (6‐65 years) with epilepsy and need of benzodiazepine rescue. Patients were stratified by average number of doses/month (<2, moderate frequency; 2‐5, high frequency; >5, very‐high frequency). Safety was evaluated based on treatment‐emergent adverse events (TEAEs), assessed nasal irritation, and olfaction. The proportion of treatments given as a second dose was used as an exploratory proxy for effectiveness.ResultsOf 175 enrolled patients (data cutoff, October 31, 2019), 158 received ≥1 dose of diazepam nasal spray. Frequency of use was moderate in 43.7% of patients, high in 50.6% of patients, and very high in 5.7% of patients. Patients treated 3397 seizure episodes (moderate frequency, 14.2%; high frequency, 59.9%; very high frequency, 25.8%). Nasal discomfort was the most common treatment‐related TEAE in all groups. No notable changes in nasal irritation or olfaction were observed. Second doses represented only 2.5%, 7.5%, and 17.2% of all doses in the moderate‐, high‐, and very‐high‐frequency groups, respectively. Overall retention rate was 82.9%, without an observed relationship to frequency of use.SignificanceFrequency of dosing diazepam nasal spray had little impact on the safety/tolerability profile across a range of <2 to >5 doses/month. Effectiveness was suggested for all dosing frequencies by the high proportion of seizure clusters not treated with a second dose. These results support the utility, safety profile, and effectiveness of diazepam nasal spray across frequencies of seizure cluster burden.
Toward a better definition of focal cortical dysplasia: An iterative histopathological and genetic agreement trial
Blümcke, Ingmar , Busch, Robyn M. , Morita‐Sherman, Marcia , Lal, Dennis , Prayson, Richard A. , Cendes, Fernando , Lopes‐Cendes, Íscia , Rogério, Fábio , Almeida, Vanessa Simão de , Sim, Nam Suk , Lee, Jeong Ho , Kim, Se Hoon , Baulac, Stéphanie , Baldassari, Sara , Adle‐Biassette, Homa , Walsh, Christopher A., Bizzotto, Sara , Doan, Ryan N. , Morillo, Katherine , Becker, Albert J. , Cienfuegos-Meza, Jesús , Honavar, Mrinalini , Mahadevan, Anita , Miyata, Hajime , Niehusmann, Pitt , Söylemezoğlu, Figen , Najm, Imad , Busch, Robyn M , Cendes, Fernando , Lopes-Cendes, Iscia , Baulac, Stephanie , Baldassari, Sara , Mühlebner, Angelika , Becker, Albert , Garbelli, Rita , Jacques, Thomas S , Thom, Maria , Mahadevan, Anita , Miyata, Hajime , Blümcke, Ingmar , Najm, Imad , Coras, Roland , Morita, Márcia Elisabete , Rocha, Cristiane S. , Aronica, Eleonora , Giannini, Caterina , Jacques, Thomas S. , Sarnat, Harvey B.

Mayo Clinic

Epilepsia | May 5, 2021 | Volume: 62 | Issue: 6 | Pages: 1416-1428

10.1111/epi.16899 | PMID 33949696 Get It

Abstract Objective Focal cortical dysplasia (FCD) is a major cause of difficult‐to‐treat epilepsy in children and young adults, and the diagnosis is currently based on microscopic review of surgical brain tissue using the International League Against Epilepsy classification scheme of 2011. We developed an iterative histopathological agreement trial with genetic testing to identify areas of diagnostic challenges in this widely used classification scheme. Methods Four web‐based digital pathology trials were completed by 20 neuropathologists from 15 countries using a consecutive series of 196 surgical tissue blocks obtained from 22 epilepsy patients at a single center. Five independent genetic laboratories performed screening or validation sequencing of FCD‐relevant genes in paired brain and blood samples from the same 22 epilepsy patients. Results Histopathology agreement based solely on hematoxylin and eosin stainings was low in Round 1, and gradually increased by adding a panel of immunostainings in Round 2 and the Delphi consensus method in Round 3. Interobserver agreement was good in Round 4 (kappa = .65), when the results of genetic tests were disclosed, namely, MTOR , AKT3 , and SLC35A2 brain somatic mutations in five cases and germline mutations in DEPDC5 and NPRL3 in two cases. Significance The diagnoses of FCD 1 and 3 subtypes remained most challenging and were often difficult to differentiate from a normal homotypic or heterotypic cortical architecture. Immunohistochemistry was helpful, however, to confirm the diagnosis of FCD or no lesion. We observed a genotype–phenotype association for brain somatic mutations in SLC35A2 in two cases with mild malformation of cortical development with oligodendroglial hyperplasia in epilepsy. Our results suggest that the current FCD classification should recognize a panel of immunohistochemical stainings for a better histopathological workup and definition of FCD subtypes. We also propose adding the level of genetic findings to obtain a comprehensive, reliable, and integrative genotype–phenotype diagnosis in the near future.
Convection-Enhanced Delivery for H3K27M Diffuse Midline Glioma: How can we Efficaciously Modulate the Blood–Brain Barrier?
Rechberger, Julian S. , Power, Erica A. , Power, Erica A , Rechberger, Julian S , Daniels, David J.

Mayo Clinic

Therapeutic Delivery | May 5, 2021 | Volume: 12 | Issue: 6 | Pages: 419-422

10.4155/tde-2021-0026 | PMID 33949200 Get It

Data Quality Assessment for Super‐Resolution Fetal Brain MR Imaging: A Retrospective 1.5 T Study
Rubert, Nicholas , Bardo, Dianna M.E. , Vaughn, Jennifer, Cornejo, Patricia , Gonçalves, Luís F. , Goncalves, Luis

Mayo Clinic

Journal of Magnetic Resonance Imaging | May 5, 2021 | Volume: 54 | Issue: 4 | Pages: 1349-1360

10.1002/jmri.27665 | PMID 33949725 Get It

Background Super‐resolution is a promising technique to create isotropic image volumes from stacks of two‐dimensional (2D) motion‐corrupted images in fetal magnetic resonance imaging (MRI). Purpose To determine an acquisition quality metric and correlate that metric with radiologist perception of three‐dimensional (3D) image quality. Study Type Retrospective. Subjects Eighty‐seven patients, mean gestational age 29 ± 6 weeks. Field Strength/Sequence 1.5 T/ 2D fast spin‐echo. Assessment Four radiologists (L.G., D.M.E.B., P.C., and J.V.; 31, 21, 7, and 7 years' experience, respectively) graded reconstructions on a 0 to 4 scale for overall appearance and visibility of specific anatomy. During reconstruction, slices were labeled as inliers based on correlation between a simulated vs. actual acquisition. The fraction of brain voxels in inlier slicers vs. total brain voxels was measured for each acquisition. Statistical Tests Paired sample t test, Pearson's correlation, intra‐class correlation. Results The average brain mask inlier fraction for all acquisitions was 0.8. There was a statistically significant correlation (0.71) between overall reconstruction appearance and number of acquisitions with inlier fraction above 0.73. There was low correlation (0.21, P = 0.05) between the number of acquisitions used in the reconstruction and overall score when no data quality measure was considered. Similar results were found for ratings of specific anatomy. Statistically significant differences in overall perception of image quality were found when using three vs. four, four vs. five, and three vs. five high‐quality acquisitions in the reconstruction. Five high‐quality acquisitions were sufficient to yield an average radiologist rating of 3.59 out of 4.0 for overall image quality. Data Conclusion Reconstruction quality can be reliably predicted using the brain mask inlier fraction. Real‐time super‐resolution protocols could exploit this to terminate acquisition when enough high‐quality acquisitions have been collected. To achieve consistent 3D image quality it may be necessary to acquire more than five scans to compensate for severely motion‐corrupted acquisitions. Level of Evidence 3 Technical Efficacy 1
Scapholunate ligament 360° procedure
Logli, Anthony L. , Ramazanian, Taghi , Gaston, R. Glenn , Fowler, John R. , Kakar, Sanjeev

Mayo Clinic

The Bone & Joint Journal | May 5, 2021 | Volume: 103-B | Issue: 5 | Pages: 939-945

10.1302/0301-620x.103b5.bjj-2020-1964.r2 | PMID 33934641 Get It

AimsThe purpose was to evaluate early clinical, patient-reported, and radiological outcomes of the scapholunate ligament 360° tenodesis (SL 360) technique for treatment of scapholunate (SL) instability.MethodsWe studied the results of nine patients (eight males and one female with a mean age of 44.7 years (26 to 55)) who underwent the SL 360 procedure for reducible SL instability between January 2016 and June 2019, and who were identified from retrospective review of electronic medical records. Final follow-up of any kind was a mean of 33.7 months (12.0 to 51.3). Clinical, radiological, and patient-reported outcome data included visual analogue scale (VAS) for pain, Quick Disabilities of the Arm, Shoulder and Hand (QuickDASH), Mayo Wrist Score (MWS), and Patient-Rated Wrist Examination (PRWE). Means were analyzed using paired t-test.ResultsBefore surgery, patients with SL instability were significantly impaired with respect to wrist flexion, extension, and grip strength (mean flexion, 51° (20° to 85°) vs 73° (45° to 90°); mean extension, 46° (15° to 70°) vs 66° (45° to 80°); mean grip strength, 25 kg (20 to 31) vs 50 kg (35 to 68) compared to the unaffected side). The mean SL gap (4.9 mm (2.3 to 7.3) vs 2.1 mm (1.6 to 2.9)) and mean SL angle (71° (59° to 105°) vs 50° (38° to 64°) were also significantly greater in the affected wrist. At final follow-up, there was mean improvement regarding clinical, radiological, and functional outcomes comparing preoperative to final postoperative values for the VAS for pain scale, QuickDASH, MWS, PRWE, and SL gap and SL angle.ConclusionIn our small series, the SL 360 procedure for reducible SL instability has favourable early clinical, patient-reported, and radiological outcomes at a mean of 33.7 months (12.0 to 51.3). The suture tape and tendon construct confers robust stability, permitting earlier mobilization without the inherent disadvantages of Kirschner wire stabilization. Cite this article: Bone Joint J 2021;103-B(5):939–945.
Radiological humeral adaptative changes five years after anatomical total shoulder arthroplasty using a standard-length cementless hydroxyapatite-coated humeral component
Nguyen, Ngoc Tram V. , Martínez‐Catalán, Natalia , Songy, Chad E. , Sánchez‐Sotelo, Joaquín , Sanchez-Sotelo, J.

Mayo Clinic

The Bone & Joint Journal | May 5, 2021 | Volume: 103-B | Issue: 5 | Pages: 958-963

10.1302/0301-620x.103b5.bjj-2020-1619.r1 | PMID 33934651 Get It

Aims The purpose of this study was to report bone adaptive changes after anatomical total shoulder arthroplasty (TSA) using a standard-length hydroxyapatite (HA)-coated humeral component, and to report on a computer-based analysis of radiographs to determine changes in peri-implant bone density objectively. Methods A total of 44 TSAs, performed between 2011 and 2014 using a cementless standard-length humeral component proximally coated with HA, were included. There were 23 males and 21 females with a mean age of 65 years (17 to 65). All shoulders had good quality radiographs at six weeks and five years postoperatively. Three observers graded bone adaptive changes. All radiographs were uploaded into a commercially available photographic software program. The grey value density of humeral radiological areas was corrected to the grey value density of the humeral component and compared over time. Results Stress shielding was graded as mild in 14 shoulders and moderate in three; the greater tuberosity was the predominant site for stress shielding. The mean metaphyseal and diaphyseal fill-fit ratios were 0.56 (SD 0.1) and 0.5 (SD 0.07), respectively. For shoulders with no radiologically visible stress shielding, the mean decrease in grey value in zones 1 and 7 was 20%, compared with 38% in shoulders with radiologically visible stress shielding. Conclusion The rate of moderate stress shielding was 7%, five years after implantation of a cementless standard-length HA-coated humeral component. Clinical observation of stress shielding identified on radiographs seems to represent a decrease in grey value of 25% or more. Cite this article: Bone Joint J 2021;103-B(5):958–963.
Impact of the Surgical Approach to Thymectomy Upon Complete Stable Remission Rates in Myasthenia Gravis
Solís-Pazmiño, Paola , Baiu, Ioana , Trope, Winston , Ponce, Oscar J. , Shrager, Joseph B. , Ponce, Oscar Josue , Lincango-Naranjo, Eddy , Prokop, Larry J.

Mayo Clinic

Neurology | May 4, 2021 | Volume: 97 | Issue: 4 | Pages: No page available

10.1212/wnl.0000000000012153 | PMID 33947783 Get It

Long-term clinical outcomes of patients receiving proton beam therapy for caudate lobe hepatocellular carcinoma
Okumura, Toshiyuki, Takahashi, Hiroaki , Tsai, Yu‐Lun , Takizawa, Daichi , Ishida, Toshiki , Hiroshima, Yuichi , Nakamura, Masatoshi , Shimizu, Shosei , Saito, Takashi , Numajiri, Haruko , Mizumoto, Masashi , Nakai, Kei , Sakurai, Hideyuki , Iizumi, Takashi , Sekino, Yuta , Takahashi, Hiroaki

Mayo Clinic

Journal of Radiation Research | May 4, 2021 | Volume: 62 | Issue: 4 | Pages: 682-687

10.1093/jrr/rrab040 | PMID 34036362 Get It

Abstract Hepatocellular carcinoma (HCC) located in the caudate lobe (caudate HCC) is rare; however, patients with this type of tumour have poorer prognoses than those with HCC in other segments. Despite many published reports on the clinical usefulness of proton beam therapy (PBT) for HCC, data on the clinical outcomes of patients undergoing PBT for caudate HCC remain scarce. Therefore, the present study aimed to investigate the outcomes of this group of patients. Thirty patients with caudate HCC who underwent definitive PBT between February 2002 and February 2014 were retrospectively analysed. The total irradiation doses ranged from 55 to 77 (median 72.6) Gy relative biological dose. The median follow-up period was 37.5 (range, 3.0–152.0) months. The overall survival (OS) rates at one, three and five years were 86.6%, 62.8% and 46.1%, respectively. According to univariate and multivariate analyses, Child-Pugh A (P &lt; 0.01), having a single tumour (P = 0.02) and a low serum alpha-fetoprotein level (AFP; P &lt; 0.01) were significant factors predicting longer survival. The local control (LC) rates at one, three and five years were 100%, 85.9% and 85.9%, respectively, while the corresponding progression-free survival (PFS) rates were 65%, 27.5% and 22%, respectively. No grade 3 or worse adverse events were observed. PBT is effective and safe for the treatment of caudate HCC, and should therefore be considered a feasible option for intervention in patients with this disease.